🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.300
-0.080 (-2.37%)
Nov 18, 2026, 10:41 AM EST - Market open

Aclaris Therapeutics Statistics

Total Valuation

ACRS has a market cap or net worth of $523.42 million. The enterprise value is $320.52 million.

Market Cap523.42M
Enterprise Value 320.52M

Important Dates

The last earnings date was Thursday, November 5, 2026, before market open.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

ACRS has 158.61 million shares outstanding. The number of shares has increased by 17.46% in one year.

Current Share Class 158.61M
Shares Outstanding 158.61M
Shares Change (YoY) +17.46%
Shares Change (QoQ) +4.70%
Owned by Insiders (%) 2.03%
Owned by Institutions (%) 61.58%
Float 113.64M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 83.75
Forward PS 108.60
PB Ratio 3.06
P/TBV Ratio 3.21
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 52.06
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.09, with a Debt / Equity ratio of 0.01.

Current Ratio 5.09
Quick Ratio 5.09
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -55.51% and return on invested capital (ROIC) is -38.85%.

Return on Equity (ROE) -55.51%
Return on Assets (ROA) -28.85%
Return on Invested Capital (ROIC) -38.85%
Return on Capital Employed (ROCE) -47.10%
Weighted Average Cost of Capital (WACC) 9.37%
Revenue Per Employee $87,685
Profits Per Employee -$1.09M
Employee Count73
Asset Turnover 0.03
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +35.51% in the last 52 weeks. The beta is 0.94, so ACRS's price volatility has been similar to the market average.

Beta (5Y) 0.94
52-Week Price Change +35.51%
50-Day Moving Average 4.28
200-Day Moving Average 4.54
Relative Strength Index (RSI) 35.98
Average Volume (20 Days) 2,760,419

Short Selling Information

The latest short interest is 11.57 million, so 7.30% of the outstanding shares have been sold short.

Short Interest 11.57M
Short Previous Month 15.03M
Short % of Shares Out 7.30%
Short % of Float 10.18%
Short Ratio (days to cover) 2.92

Income Statement

In the last 12 months, ACRS had revenue of $6.40 million and -$79.63 million in losses. Loss per share was -$0.59.

Revenue6.40M
Gross Profit -66.00M
Operating Income -90.41M
Pretax Income -79.63M
Net Income -79.63M
EBITDA n/a
EBIT -90.41M
Loss Per Share -$0.59
Full Income Statement

Balance Sheet

The company has $204.61 million in cash and investments and $1.71 million in debt, with a net cash position of $202.90 million or $1.28 per share.

Cash & Investments 204.61M
Total Debt 1.71M
Net Cash 202.90M
Net Cash Per Share $1.28
Equity (Book Value) 166.80M
Book Value Per Share 1.11
Working Capital 99.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.21 million and capital expenditures -$108,000, giving a free cash flow of -$75.32 million.

Operating Cash Flow -75.21M
Capital Expenditures -108,000
Depreciation & Amortization 411,000
Net Borrowing n/a
Free Cash Flow -75.32M
FCF Per Share -$0.47
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,412.40%
Pretax Margin -1,244.09%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ACRS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -17.46%
Shareholder Yield -17.46%
Earnings Yield -17.75%
FCF Yield -14.05%

Analyst Forecast

The average price target for ACRS is $9.82, which is 197.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.82
Price Target Difference 197.52%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (3Y) -10.46%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ACRS has an Altman Z-Score of -1.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.01
Piotroski F-Score 2